| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c5a403f715557c84d6771768e30f7eb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2013-00089
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-254
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2013-530802
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2013-530226
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-00063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-51121
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-51113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-00068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-15699
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-425 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-00 |
| filingDate |
2018-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a64944a7921788f163125341bfe85dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed854cc4b74e1bd958bcf596a8f11c51 |
| publicationDate |
2019-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019118631-A1 |
| titleOfInvention |
Debriding wound dressing, process of manufacture and useful articles thereof |
| abstract |
This invention describes a wound dressing product for active continuous debridement of devitalized tissues in non-healing wounds including diabetic ulcers, pressure ulcers, burn injuries and other etiologies. The present invention pertains to the principle of continuous wound debridement which makes necrotic tissue more susceptible for removal and hence enhances progressive wound healing. The dressing contains an active ingredient, such as collagenase which serves to debride wounds in-situ. In the present invention purified Collagenase (90% pure) was deposited onto several wound dressing materials. A key feature of this invention is that the activity level of the Collagenase used was substantially preserved. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114288459-A |
| priorityDate |
2017-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |